Latest news

Latest Intelligence

• How diversity and inclusion continues to be incorporated in dermatology

  2. It observed that it is “vital that the language used for describing rashes/lesions in dermatology is updated, to be inclusive and reflective of the UK’s ethnic diversity.” Demand ... Addressing diversity and inclusivity to achieve optimal

• Patient diversity in clinical trials needs to be centre stage

  There is a lot to address.”. Understanding all factors. COUCH Health has just published the second issue of its Demand Diversity reports, which is a call to action to tackle the ... It’s not; it’s a health equality issue. There is need for more

• Diversity and inclusion in clinical trials

  ways, the FDA guidance issued in November that addressed the multidimensional aspects of diversity and inclusion in clinical trials, and the coverage of social unrest with the demand for equity featured ... The coronavirus pandemic placed clinical

Latest from PMHub

• #DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials

  In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. ... If you’re interested in getting involved in our mission to Demand Diversity, get in touch at ash@demanddiversity.co.

• How do ethnic minority groups in the U.S. view clinical trials?

  The Demand Diversity research found that there are two key themes that contributed to medical mistrust — unequal treatment and money. ... Moving forward, we must rectify medical mistrust and form trustworthy relationships with these communities, as

• Include Us All in Your Clinical Trials

  44 (0) 330 995 0656. Address:. Suite 2.10, Jactin House. 24 Hood Street. Manchester. M4 6WX. United Kingdom.

• #DemandDiversity: We’re calling on the clinical trials industry to include us all

  The lack of diversity in clinical trials is something we’ve spoken about time and time again. ... difference? The lack of diversity in clinical trials is something we’ve spoken about time and time again.

• COUCH Health Explores Lack of Ethnic Minorities in U.S. Clinical Trials

  and as the pharmaceutical industry has begun to tackle its diversity and inclusion problem. ... Without their participation, clinical trials simply aren’t reflecting real-life population diversity, and clinical trial efficacy will be compromised.”.